Global Research on Neuropathic Pain Rehabilitation over the Last 20 Years
Neural Plasticity · 07.07.2021 · 2021 · 1-13
DOI: 10.1155/2021/5594512 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neural Plasticity, erschienen am 07.07.2021. Verfasst von Xuan Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sport Rehabilitation, Shanghai University of Sport, 399 Changhai Rd., Shanghai 200438, China. Hauptthemen laut MEDLINE: Bibliometrics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Family Planning Commission of Sichuan Province, Key Laboratory Program of Assessment and Regulation of Sport Cognition of the General Administration of Sport of China, Shanghai University of Sport.
Abstract (Originalsprache)
Background
Neuropathic pain has long been a very popular and productive field of clinical research. Neuropathic pain is difficult to cure radically because of its complicated etiology and uncertain pathogenesis. As pain worsens and persists, pain recovery techniques become more important, and medication alone is insufficient. No summary of bibliometric studies on neuropathic pain rehabilitation is yet available. The purpose of the present study is to analyze in a systematic manner the trends of neuropathic pain rehabilitation research over the period of 2000–2019.
Methods
Studies related to neuropathic pain rehabilitation and published between January 2000 and December 2019 were obtained from the Science Citation Index-Expanded of Web of Science. No restrictions on language, literature type, or species were established. CiteSpace V and Microsoft Excel were used to capture basic information and highlights in the field.
Results
Linear regression analysis showed that the number of publications on neuropathic pain rehabilitation significantly increased over time ( P < 0.001 ). The United States showed absolute strength in terms of number of papers published, influence, and cooperation with other countries. Based on the subject categories of the Web of Science, “Rehabilitation” had the highest number of published papers (446), the highest number of citations (10,954), and the highest number of open-access papers (151); moreover, this category and “Clinical Neurology” had the same H -index (i.e., 52). “Randomized Controlled Trials” revealed the largest cluster in the cocitation map of references. The latest burst keywords included “Exercise” (2014–2019), “Functional Recovery” (2015–2019), and “Questionnaire” (2015–2019).
Conclusion
This study provides valuable information for neuropathic pain rehabilitation researchers seeking fresh viewpoints related to collaborators, cooperative institutions, and popular topics in this field. Some new research trends are also highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Sport Rehabilitation, Shanghai University of Sport, 399 Changhai Rd., Shanghai 200438, China.
- Department of Rehabilitation Medicine, Shanghai Shangti Orthopaedic Hospital, 188 Hengren Rd., Shanghai 200438, China.
- Department of Sport Psychology, Shanghai University of Sport, Shanghai 200438, China.
Förderung
- Health and Family Planning Commission of Sichuan Province
- Key Laboratory Program of Assessment and Regulation of Sport Cognition of the General Administration of Sport of China
- Shanghai University of Sport
Zitieren
APA
Su, X., Hu, H. Y., & Xu, C. (2021). Global Research on Neuropathic Pain Rehabilitation over the Last 20 Years. Neural Plasticity, 2021, 1-13. https://doi.org/10.1155/2021/5594512
Vancouver
Su X, Hu HY, Xu C. Global Research on Neuropathic Pain Rehabilitation over the Last 20 Years. Neural Plasticity. 2021;2021:1-13. doi:10.1155/2021/5594512
BibTeX
@article{Su2021,
author = {Su, Xuan and Hu, Hao-Yu and Xu, Chang},
title = {Global Research on Neuropathic Pain Rehabilitation over the Last 20 Years},
journal = {Neural Plasticity},
year = {2021},
volume = {2021},
pages = {1--13},
doi = {10.1155/2021/5594512}
}
EUVIMED